• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国年轻女性中,乳房切除术在乳腺导管原位癌治疗中的使用日益增加。

Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States.

作者信息

Rutter Charles E, Park Henry S, Killelea Brigid K, Evans Suzanne B

机构信息

Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA,

出版信息

Ann Surg Oncol. 2015 Jul;22(7):2378-86. doi: 10.1245/s10434-014-4334-x. Epub 2015 Jan 7.

DOI:10.1245/s10434-014-4334-x
PMID:25564175
Abstract

BACKGROUND

Ductal carcinoma-in situ (DCIS) is a preinvasive form of breast cancer associated with excellent outcomes after either mastectomy or breast conservation therapy. Previous studies have demonstrated declining rates of mastectomy. However, it is unclear how this pattern has changed in recent years.

METHODS

Women with DCIS were identified within the National Cancer Data Base. Patients treated with lumpectomy with or without radiotherapy were compared to women treated with mastectomy on the basis of demographic, clinicopathologic, and reporting facility details using χ (2) tests and multivariable logistic regression modeling to identify factors that may influence surgical choice. Changes in the proportion of women receiving contralateral prophylactic mastectomy (CPM) were assessed in a similar fashion.

RESULTS

We identified 212,936 women diagnosed with DCIS between 1998 and 2011. Lumpectomy was performed in 68 % (144,681) of patients. Mastectomy rates initially declined from 1998 (36 %) through 2004 (28 %), before increasing again through 2011 (33 %). Younger patient age, greater medical comorbidity, more extensive disease, higher tumor grade, treatment at an academic facility, and greater distance from the reporting facility were associated with heightened use of mastectomy (all p < 0.001). CPM also increased over time, particularly among younger patients, on multivariate analysis (p < 0.001).

CONCLUSIONS

Mastectomy utilization appears to be rising between 2004 and 2011, particularly among younger patients and those with higher-risk histopathologic features. CPM is increasing in a similar fashion. Further research is needed to understand the drivers of this change.

摘要

背景

导管原位癌(DCIS)是一种乳腺癌的浸润前形式,在乳房切除术或保乳治疗后预后良好。既往研究显示乳房切除术的比例呈下降趋势。然而,近年来这种模式如何变化尚不清楚。

方法

在国家癌症数据库中识别出患有DCIS的女性。根据人口统计学、临床病理和报告机构的详细信息,使用χ²检验和多变量逻辑回归模型,将接受保乳手术(无论是否接受放疗)的患者与接受乳房切除术的女性进行比较,以确定可能影响手术选择的因素。以类似方式评估接受对侧预防性乳房切除术(CPM)的女性比例的变化。

结果

我们识别出1998年至2011年间被诊断为DCIS的212,936名女性。68%(144,681)的患者接受了保乳手术。乳房切除术的比例最初从1998年(36%)下降至2004年(28%),随后在2011年再次上升(33%)。患者年龄较轻、合并症较多、疾病范围更广、肿瘤分级更高、在学术机构接受治疗以及距离报告机构更远与更高的乳房切除术使用率相关(所有p<0.001)。多变量分析显示,CPM也随时间增加,尤其是在年轻患者中(p<0.001)。

结论

2004年至2011年间乳房切除术的使用率似乎在上升,尤其是在年轻患者和具有高风险组织病理学特征的患者中。CPM也以类似方式增加。需要进一步研究以了解这种变化的驱动因素。

相似文献

1
Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States.美国年轻女性中,乳房切除术在乳腺导管原位癌治疗中的使用日益增加。
Ann Surg Oncol. 2015 Jul;22(7):2378-86. doi: 10.1245/s10434-014-4334-x. Epub 2015 Jan 7.
2
Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base.2003 年至 2010 年轻乳腺癌患者外科治疗趋势的变化:来自国家癌症数据库的报告。
J Am Coll Surg. 2014 Jul;219(1):19-28. doi: 10.1016/j.jamcollsurg.2014.03.043. Epub 2014 Apr 1.
3
Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.乳房重建对接受对侧预防性乳房切除术决策的影响。
Ann Surg Oncol. 2014 Sep;21(9):2934-40. doi: 10.1245/s10434-014-3712-8. Epub 2014 Apr 23.
4
Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.与乳腺癌患者对侧预防性乳房切除术使用增加相关的患者及外科医生特征。
Ann Surg Oncol. 2009 Oct;16(10):2697-704. doi: 10.1245/s10434-009-0641-z. Epub 2009 Aug 4.
5
Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.导管原位癌患者中对侧预防性乳房切除术的比例不断上升。
J Clin Oncol. 2009 Mar 20;27(9):1362-7. doi: 10.1200/JCO.2008.20.1681. Epub 2009 Feb 17.
6
Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.对比乳腺癌患者接受对侧预防性乳房切除术与单侧全乳房切除术的患者特征和结局。
Ann Surg Oncol. 2012 Aug;19(8):2600-6. doi: 10.1245/s10434-012-2299-1. Epub 2012 Mar 7.
7
Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy.即刻乳房重建的应用及对侧预防性乳房切除术的选择。
Surgery. 2016 Apr;159(4):1199-209. doi: 10.1016/j.surg.2015.11.001. Epub 2015 Dec 17.
8
Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base.1998年至2011年年轻乳腺癌女性对侧预防性乳房切除术率按种族分组的差异:来自国家癌症数据库的报告
J Am Coll Surg. 2015 Jul;221(1):187-96. doi: 10.1016/j.jamcollsurg.2015.03.033. Epub 2015 Apr 23.
9
Incidence of and treatment for ductal carcinoma in situ of the breast.乳腺导管原位癌的发病率及治疗方法
JAMA. 1996 Mar 27;275(12):913-8.
10
Mastectomy and contralateral prophylactic mastectomy rates: an institutional review.乳房切除术和对侧预防性乳房切除术的比率:机构审查。
Ann Surg Oncol. 2011 May;18(5):1356-63. doi: 10.1245/s10434-010-1434-0. Epub 2010 Dec 2.

引用本文的文献

1
Nonclinical factors associated with the treatment of older women with newly diagnosed low-grade ductal carcinoma in situ.与新诊断为低级别导管原位癌的老年女性治疗相关的非临床因素。
Cancer. 2024 Apr 1;130(7):1041-1051. doi: 10.1002/cncr.35124. Epub 2023 Nov 21.
2
Current Considerations in Surgical Treatment for Adolescents and Young Women with Breast Cancer.青少年及年轻女性乳腺癌外科治疗的当前考量
Healthcare (Basel). 2022 Dec 15;10(12):2542. doi: 10.3390/healthcare10122542.
3
Understanding Stakeholder Preference for Contralateral Prophylactic Mastectomy: A Conjoint Analysis.
理解利益相关者对预防性对侧乳房切除术的偏好:联合分析。
J Am Coll Surg. 2021 Nov;233(5):606-618.e1. doi: 10.1016/j.jamcollsurg.2021.06.025. Epub 2021 Aug 23.
4
Local Recurrence in Young Women with Breast Cancer: Breast Conserving Therapy vs. Mastectomy Alone.年轻乳腺癌女性的局部复发:保乳治疗与单纯乳房切除术对比
Cancers (Basel). 2021 Apr 29;13(9):2150. doi: 10.3390/cancers13092150.
5
Treatment of Ductal Carcinoma in Situ: Considerations for Tailoring Therapy in the Contemporary Era.导管原位癌的治疗:当代个性化治疗的考量
Curr Breast Cancer Rep. 2020 Jun;12(2):98-106. doi: 10.1007/s12609-020-00360-5. Epub 2020 Feb 24.
6
The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer.安吉丽娜·朱莉效应:高乳腺癌风险患者行预防性对侧乳房切除术的趋势。
Sci Rep. 2021 Feb 2;11(1):2847. doi: 10.1038/s41598-021-82654-x.
7
Ductal carcinoma in situ (DCIS): The importance of patient-reported outcomes (PRO).导管原位癌(DCIS):患者报告结局(PRO)的重要性。
Curr Breast Cancer Rep. 2020 Jun;12(2):90-97. doi: 10.1007/s12609-020-00363-2. Epub 2020 Apr 4.
8
Adoption of SSO-ASTRO Margin Guidelines for Ductal Carcinoma in Situ: What Is the Impact on Use of Additional Surgery?采用美国放射肿瘤学会(ASTRO)导管原位癌切缘指南:对额外手术使用情况有何影响?
Ann Surg Oncol. 2021 Jan;28(1):295-302. doi: 10.1245/s10434-020-08610-7. Epub 2020 Jun 4.
9
ASO Author Reflections: Advising a Woman with Ductal Carcinoma In Situ Regarding Various Treatment Options-A Complex Decision.ASO作者反思:就多种治疗方案为一位导管原位癌女性提供建议——一个复杂的决定。
Ann Surg Oncol. 2019 Dec;26(13):4272-4273. doi: 10.1245/s10434-019-07859-x. Epub 2019 Sep 23.
10
Ductal Carcinoma in Situ: Current Concepts in Biology, Imaging, and Treatment.导管原位癌:生物学、影像学及治疗的当前概念
J Breast Imaging. 2019 Sep;1(3):166-176. doi: 10.1093/jbi/wbz039. Epub 2019 Aug 18.